Ritonavir (Norvir)
Overview
- A Clinical Overview of Ritonavir (Norvir) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health - Dosing for Ritonavir-Boosted Protease Inhibitors (November 2007)
From HIV InSite - Prescribing Information for Ritonavir (Norvir) (PDF) (May 2007)
From Abbott Laboratories - My Friend Ritonavir: The Concept of "Boosting" (December 2004)
This research update reviews what we know about boosting HAART regimens with ritonavir (free registration required).
In The PRN Notebook - Drug Interactions: Ritonavir (August 2004)
From Project Inform - Protease Inhibitor Therapy: Boosted and Double-Boosted Options to the Fore (March 2004)
In The PRN Notebook - Drug Interactions: Ritonavir as PI Booster (July 2001)
From Project Inform
News
- Ritonavir Price Increase Responses (Regularly Updated)
To help its members remain informed, the Academy has compiled the following list of letters from various organizations and groups of providers responding to the price increase.
From American Academy of HIV Medicine - Updated Labeling for Norvir (Ritonavir) Soft Capsule and Oral Solution (September 2, 2008)
From U.S. Food and Drug Administration - Newly-Unsealed Documents Shed Light on Abbott Labs' 400% Norvir Price Hike (May 12, 2008)
Union, consumer groups decry Abbott for putting profits before HIV/AIDS patients' needs
In A Closer Walk: A Film by Robert Bilheimer, from Community Catalyst - GSK Joins Lawsuit Against Abbott Over Price of Ritonavir (November 12, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Pharmacies, Drug Wholesaler File Lawsuit Against Abbott Over Ritonavir Price (October 30, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - New Dosing Regimen for Fosamprenavir Approved: Ritonavir Dose Reduced (October 12, 2007)
From U.S. Food and Drug Administration - Interaction Warning: Ritonavir and Blood-Pressure Drug Nifedipine (December 12, 2006)
From aidsmap.com - FDA Approves Pediatric Dosing for Ritonavir (October 6, 2005)
From U.S. Food and Drug Administration - Norvir (Ritonavir) 100 mg Now Available in 30-Count Bottle (May 13, 2005)
From U.S. Food and Drug Administration - AIDS Treatment Activists Coalition: AIDS Activists Outraged by Abbott Settlement With AIDS Healthcare Foundation (July 16, 2004)
To read PDF, click here
From AIDS Treatment Activists Coalition - Food and Drug Administration Warning Letter to Abbott Laboratories (PDF) (June 10, 2004)
The FDA warns Abbott Laboratories that some of its marketing of its AIDS drug ritonavir (Norvir) in certain patient information materials is false and misleading.
From U.S. Food and Drug Administration - Ritonavir Sales Projected to Top $2B in Next Decade; Insurers' Costs Skyrocket (June 7, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Aetna Files Lawsuit Against Abbott Over 400% Price Increase of Ritonavir (May 27, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - U.S. Government Holds Hearing on Generic Production of Ritonavir (May 26, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Abbott's Norvir Price Hike Is Bad Medicine (May/June 2004)
Bob Huff explains why the December 2003 ritonavir price increase may well doom the development of boosted protease inhibitors.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Two HIV-Infected Patients File U.S. Antitrust Suit Against Ritonavir Price Hike (April 20, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Hearing on Drug Reimportation to Include Discussion of Abbott's Pricing of Antiretroviral Norvir (April 14, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - AIDS Healthcare Foundation Files Suit Against Abbott Alleging False Advertising After 400% Price Increase on AIDS Drug (March 19, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Abbott Offers Concessions in Response to Wide Protest of Ritonavir Price Hike (PDF) (February 4, 2004)
From Abbott Laboratories - AAHIVM Urges Abbott to Reconsider Ritonavir Price Increase (January 2, 2004)
From American Academy of HIV Medicine - HIVMA Asks Abbott to Reconsider Price Hike (December 18, 2003)
From HIV Medicine Association - Rescue Regimens: The Value of Protease-Inhibitor Boosting (September 2001)
In Body Positive, from Body Positive
Clinical Management
Clinical Management
  |